110 related articles for article (PubMed ID: 31102443)
1. Analytical Treatment Interruptions and Human Immunodeficiency Virus Cure Research: Seizing the Opportunity While Maintaining Safety and Respect.
Hardy WD
Clin Infect Dis; 2020 Mar; 70(7):1418-1420. PubMed ID: 31102443
[No Abstract] [Full Text] [Related]
2. Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies.
Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
AIDS Res Ther; 2020 Nov; 17(1):65. PubMed ID: 33168019
[TBL] [Abstract][Full Text] [Related]
3. Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
Lau JSY; Cromer D; Pinkevych M; Lewin SR; Rasmussen TA; McMahon JH; Davenport MP
J Infect Dis; 2022 Aug; 226(2):236-245. PubMed ID: 35104873
[TBL] [Abstract][Full Text] [Related]
4. Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection.
Huiting ED; Gittens K; Justement JS; Shi V; Blazkova J; Benko E; Kovacs C; Wender PA; Moir S; Sneller MC; Fauci AS; Chun TW
J Infect Dis; 2019 Jun; 220(2):270-274. PubMed ID: 30840763
[TBL] [Abstract][Full Text] [Related]
5. Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium.
Eyal N; Deeks SG
J Infect Dis; 2019 Jul; 220(220 Suppl 1):S1-S4. PubMed ID: 31264687
[TBL] [Abstract][Full Text] [Related]
6. Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention.
Gayle H; Lange JM
Lancet; 2004 Jul 3-9; 364(9428):6-8. PubMed ID: 15234835
[No Abstract] [Full Text] [Related]
7. Long-Acting Injectable Antiretroviral Therapy: An Opportunity to Improve Human Immunodeficiency Virus (HIV) Treatment and Reduce HIV Transmission Among Persons Being Released From Prison Facilities.
Brinkley-Rubinstein L; Rosen DL; Christopher P; Bazerman L; Beckwith CG
Clin Infect Dis; 2017 Oct; 65(7):1247-1248. PubMed ID: 28549121
[No Abstract] [Full Text] [Related]
8. The Essential Need for Trust When Transmission Risk Cannot Be Eliminated in HIV-Remission Trials.
Rennie S; Henderson G; Phanuphak N; Kuczynski K; Colby D; Ormsby N; Kroon E; Hsu D; Likhitwonnawut U; Vasan S; Sacdalan C; Jupimai T; Butterworth O; Peay H
Ethics Hum Res; 2023; 45(4):2-15. PubMed ID: 37368521
[TBL] [Abstract][Full Text] [Related]
9. Impact of analytical treatment interruption on the central nervous system in a simian-HIV model.
Hsu DC; Silsorn D; Inthawong D; Kuncharin Y; Sopanaporn J; Im-Erbsin R; Chumpolkulwong K; O'connell RJ; Michael NL; Ege CA; Vasan S
AIDS; 2019 Dec; 33 Suppl 2():S189-S196. PubMed ID: 31789818
[TBL] [Abstract][Full Text] [Related]
10. Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
Papasavvas E; Lada SM; Joseph J; Yin X; Liu Q; Azzoni L; Mounzer K; Kostman JR; Richman D; Montaner LJ
AIDS; 2018 Aug; 32(13):1763-1772. PubMed ID: 30045057
[TBL] [Abstract][Full Text] [Related]
11. For human immunodeficiency virus disease, more treatment seems to be better: comment on "Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion".
Katz MH
Arch Intern Med; 2012 Sep; 172(16):1256. PubMed ID: 22824829
[No Abstract] [Full Text] [Related]
12. Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions.
Worthington MG; Ross JJ
AIDS; 2003 Sep; 17(14):2145-6. PubMed ID: 14502028
[No Abstract] [Full Text] [Related]
13. The current state of an HIV cure: innovative approaches and limitations.
EBioMedicine; 2019 Apr; 42():1-2. PubMed ID: 31036347
[No Abstract] [Full Text] [Related]
14. [Towards eradication of human immunodeficiency virus (HIV)?].
Katlama C
Bull Acad Natl Med; 2013 Jun; 197(6):1177-85. PubMed ID: 25803930
[TBL] [Abstract][Full Text] [Related]
15. HIV: Cure by killing.
Richman DD
Nature; 2015 Dec; 528(7581):198-9. PubMed ID: 26633623
[No Abstract] [Full Text] [Related]
16. HIV cure research: advances and prospects.
Passaes CP; Sáez-Cirión A
Virology; 2014 Apr; 454-455():340-52. PubMed ID: 24636252
[TBL] [Abstract][Full Text] [Related]
17. Reconsidering early HIV treatment and supervised treatment interruptions.
Koup RA
PLoS Med; 2004 Nov; 1(2):e41. PubMed ID: 15578109
[TBL] [Abstract][Full Text] [Related]
18. HIV reservoirs as obstacles and opportunities for an HIV cure.
Chun TW; Moir S; Fauci AS
Nat Immunol; 2015 Jun; 16(6):584-9. PubMed ID: 25990814
[TBL] [Abstract][Full Text] [Related]
19. An HIV cure: feasibility, discovery, and implementation.
Fauci AS; Marston HD; Folkers GK
JAMA; 2014 Jul 23-30; 312(4):335-6. PubMed ID: 25038345
[No Abstract] [Full Text] [Related]
20. Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy.
Martínez-Bonet M; Puertas MC; Fortuny C; Ouchi D; Mellado MJ; Rojo P; Noguera-Julian A; Muñoz-Fernández MA; Martinez-Picado J
Clin Infect Dis; 2015 Oct; 61(7):1169-78. PubMed ID: 26063721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
